Stockholm Business Region: Investment Strategies of Corporate Venture Capital in Life Science Industry Revealed
12/14/2011 7:07:03 AM
STOCKHOLM--(BUSINESS WIRE)--One of the most important sources of capital supply for small and medium-sized life science enterprises is the large pharmaceutical companies’ own venture capital operations, so-called corporate venture capital companies. Farhang Modaresi and Parhat Hebibul, master students in Karolinska Institutet’s bioentrepreneurship program, were commissioned by Stockholm Business Region to map the last ten years’ investments globally and interview key individuals to investigate the decision-making process.
comments powered by